Pfizer, Merck strike deal to develop cancer tumor treatment

by magna / Monday, 17 November 2014 / Published in Capital Market News

Germany’s Merck will get $850 million upfront to work on the product, but Pfizer downgrades its 2014 EPS view as a result of the transaction.

TOP